APA
Gehringer F., Weissinger S. E., Swier L. J., Möller P., Wirth T. & Ushmorov A. (2019). FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma. : Cancers.
Chicago
Gehringer Franziska, Weissinger Stephanie E, Swier Lotteke Jym, Möller Peter, Wirth Thomas and Ushmorov Alexey. 2019. FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma. : Cancers.
Harvard
Gehringer F., Weissinger S. E., Swier L. J., Möller P., Wirth T. and Ushmorov A. (2019). FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma. : Cancers.
MLA
Gehringer Franziska, Weissinger Stephanie E, Swier Lotteke Jym, Möller Peter, Wirth Thomas and Ushmorov Alexey. FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma. : Cancers. 2019.